FLAGSTAFF, Ariz. (November 23, 2021) — This pivotal study will determine safety and effectiveness of a modular device designed to be a completely off-the-shelf endovascular solution for aortic aneurysms involving the visceral branch vessels.

FLAGSTAFF, Ariz. (August 19, 2021) — W. L. Gore & Associates (Gore), today announced that five-year results of the U.S. prospective, multicenter study (N = 63) of endovascular repair of iliac aneurysms using the GORE® EXCLUDER® Iliac Branch Endoprosthesis (IBE) were presented at the 2021 Society for Vascular Surgery Annual Meeting. Results of the study confirmed the safety, efficacy and durability of the IBE for treatment of aortoiliac and iliac artery aneurysms.

Putzbrunn, Germany (JULY 9, 2025) — W. L. Gore & Associates (Gore) announces CE Mark approval of an expanded indication for the GORE^® VIABAHN^® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) when used as a bridging stent with branched and fenestrated aortic endografts^† in the treatment of aortic aneurysms involving the renal and mesenteric arteries.

Putzbrunn, GERMANY (16 February, 2023) — W. L. Gore & Associates, Inc. (Gore) announced that it is initiating the EMBRACE Registry to capture real-world data about the GORE^® VIABAHN^® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) used as a bridging stent in conjunction with a branched/fenestrated stent graft.

PUTZBRUNN, Germany (January 13, 2025) — As part of efforts to continuously improve medical solutions for patients with complex vascular disease, W. L. Gore & Associates, Inc. Medical Products (Gore) announced recent CE mark of a lower profile GORE^® VIABAHN^® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft).